Infusion Pumps Market is estimated to be valued at USD 11.31 Bn in 2025 and is expected to reach USD 19.89 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of8.4% from 2025 to 2032.
The global Infusion Pumps Market is experiencing consistent growth, fuelled by the rising incidence of chronic diseases, surgical procedures, and demand for precise drug delivery systems. Major product categories include large volume pumps, syringe pumps, and ambulatory pumps, with large volume pumps leading due to their widespread hospital use and reliability. Technological innovations and the expansion of home-based care are driving market adoption.
|
Current Event |
Description and its impact |
|
Technology Advancements and Innovation Impact |
|
|
Regulatory Shifts and Compliance Trends |
|
|
Product Innovation and Technological Disruption |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The infusion pumps market is witnessing robust R&D activity with a strong pipeline of advanced and smart infusion devices aimed at improving drug delivery accuracy, patient safety, and connectivity. Major players like Baxter, Becton Dickinson, and ICU Medical are developing next-generation infusion systems that integrate with electronic health records (EHRs) and offer wireless connectivity for remote monitoring. Several innovations are underway, including wearable infusion pumps, closed-loop insulin delivery systems, and multi-channel devices designed for complex therapies.
Companies are also focusing on miniaturization, longer battery life, and enhanced user interfaces to support home care and ambulatory settings. Regulatory bodies, including the U.S. FDA and European Medicines Agency, are actively reviewing a growing number of pre-market submissions, reflecting increased innovation across the sector. The expanding pipeline, particularly in oncology, diabetes management, and pain therapy, underscores a strong growth trajectory for the infusion pumps market in the coming years.
The patent landscape in the infusion pumps market highlights a surge of innovation, particularly in smart, connected delivery systems. In February 2024, Baxter International was granted a patent (US11992651B2) for a novel flow rate compensation system that allows stacked infusion pumps to autonomously adjust delivery rates based on spatial positioning and communication protocols including Bluetooth and Wi‑Fi.
Another recent patent (US11,911,590) enables integration of infusion pumps with remote electronic devices, facilitating enhanced remote control and monitoring via smartphones and tablets and reinforcing connectivity trends in device design.
Furthermore, Baxter’s earlier acquisition of Sigma International enabled access to Spectrum smart infusion pump platforms, focused on wireless drug library updates, improved safety algorithms, and compact design for bedside use.
Meanwhile, IRadimed holds patents (e.g. US10,617,821 B2) for wireless remote control of MRI-compatible infusion pumps, signaling ongoing emphasis on remote-enabled and specialty-device innovation.
Overall, the patent ecosystem reflects strong activity in technologies supporting flow optimization, connectivity, remote control, and smart safety features reinforcing competitive differentiation and boosting market entry barriers.
Reimbursement significantly influences infusion pump adoption, particularly in the U.S., Europe, and select Asia‑Pacific nations.
Healthcare professionals increasingly prefer infusion pumps due to their precision, safety, and ability to streamline medication administration across various clinical settings. Among the options available, large volume infusion pumps are favoured in hospital and critical care environments for continuous drug and fluid delivery. These pumps support high-flow rates, programmable features, and compatibility with electronic medical records (EMRs), which enhances dosing accuracy and patient monitoring.
Ambulatory and smart infusion pumps are gaining preference in outpatient and home care settings, especially for pain management, chemotherapy, and chronic illness treatment, due to their portability, remote monitoring capabilities, and reduced risk of medication errors.
Prescribers value devices with integrated drug libraries, alarm systems, and connectivity features, as these minimize adverse events and improve workflow efficiency. Furthermore, the growing adoption of interoperable and wireless-enabled pumps aligns with clinicians’ increasing focus on personalized medicine and patient-centric care delivery models.
Elastomeric pumps, also known as balloon pumps, are used to administer liquid drugs such as local anesthetics, analgesics, cytostatics, or antibiotics (depending on a therapy). They are designed for continuous drug delivery, on-demand delivery, or combination of both continuous and on-demand drug delivery. Thus, with the increasing number of surgical procedures, the use and/or demand for infusion pumps is also increasing with the rapid pace. This trend is expected to continue over the forecast period, driving the growth of the infusion pump market.
In December 2024, Healthcare IT News detailed how the Ivenix smart infusion pump system—featuring a smartphone‑style interface, automatic software updates, and streamlined administration sets—aims to reduce nurse workload and minimize medication errors. The system is being adopted across hospitals seeking enhanced operational efficiency and patient safety.
Volumetric infusion pumps have a wide range of applications in disease management as well as in parenteral nutrition compared to other pumps. The high demand for volumetric pumps is attributed to the safety, accuracy and simplicity of these pumps.
Moreover, the adoption of technologically advanced volumetric pumps with capabilities, such as electronic health record (EHR) integration, built-in security systems, and others is expected to augment the market growth. This trend is also expected to continue over the forecast period.
The increase in demand for infusion pumps across the globe is expected to provide significant growth opportunities for players in the global infusion pump market. Infusion pumps are widely used to deliver nutrients or medications in small or large amounts—such as insulin or other hormones, pain relievers, antibiotics, and chemotherapy drugs.
In November 2022, Medtronic plc announced the U.S. launch of the Medtronic Extended infusion set, the first and only infusion set labelled for up to 7-day wear. An infusion set delivers insulin from an insulin pump to the body and typically requires a set change every two to three days.
A particularly growing area of interest is the use of infusion pumps in emergency settings, where rapid, accurate, and controlled drug delivery can be critical in stabilizing patients. These devices are essential in trauma care, intensive care units, and ambulances for administering life-saving medications such as vasopressors, anaesthetics, and fluids under time-sensitive conditions.
Technological advancements and the rising adoption of smart infusion pumps are also expected to offer lucrative growth opportunities for market players. Companies are increasingly focusing on developing and launching smart, technologically advanced infusion systems.
For instance, in December 2022, Baxter received 510(k) clearance for its new Novum IQ syringe infusion pump, which can fully integrate with hospital electronic medical records (EMR) through Baxter’s IQ Enterprise Connectivity Suite. Novum IQ SYR offers enhanced safety features and is designed to deliver optimal accuracy capabilities that are especially valuable in both routine care and emergency medical scenarios.
Segmental Insights
To learn more about this report, Download Free Sample
Among product types, Large Volume Infusion Pumps are projected to lead the global infusion pumps market, accounting for approximately 27.2% of the total market share in 2025. This dominance stems from their widespread use in hospitals and clinical settings, where they are relied upon to deliver fluids, medications, and nutrients with precision over extended durations.
These pumps are indispensable in critical care units, oncology treatments, surgical procedures, and anaesthesia administration, owing to their high flow rate capability and advanced programmable features that ensure accurate dosage control. Their integration with electronic medical records and safety alarms further enhances treatment reliability and patient safety.
Despite increasing adoption of smart and portable pumps, large volume infusion pumps remain the preferred choice in inpatient settings, especially for managing post-operative care, chronic disease therapy, and fluid management protocols, reinforcing their market dominance across both developed and emerging healthcare systems.
To learn more about this report, Download Free Sample
North America is expected to dominate the global Infusion Pumps Market, accounting for an estimated 40.10% market share in 2025. This leadership position is driven by a combination of robust healthcare infrastructure, favourable reimbursement systems, and high adoption rates of cutting-edge medical technologies across the U.S. and Canada.
The region faces a substantial burden of chronic diseases, including diabetes, cancer, and cardiovascular conditions, all of which necessitate ongoing and precise infusion therapies. An aging population, increasing hospitalization rates, and the growing shift toward home-based care further amplify the demand for reliable infusion solutions.
A key trend shaping the market is the rising adoption of infusion pumps with Bluetooth connectivity, which allow seamless communication between devices, patients, and healthcare providers. These smart pumps enhance remote monitoring, enable real-time data transmission to electronic medical records (EMRs), and support timely clinical decisions particularly valuable in home healthcare and outpatient settings.
Additionally, major global players in the infusion pumps market have significant operations or headquarters in North America, contributing to continual innovation, FDA approvals, and the integration of smart infusion technologies. Continued investment in R&D and connected healthcare platforms reinforces the region’s strategic advantage in advancing infusion therapy solutions, including the growing deployment of Bluetooth-enabled pumps designed to improve patient outcomes and medication safety.
The United States holds the largest share of the global infusion pumps market within the North American region, which is projected to account for 40.1% of the global market in 2025. This dominance is attributed to its well-established healthcare infrastructure, advanced clinical practices, and favourable reimbursement policies from both public and private insurers.
A high incidence of chronic illnesses, such as diabetes, cancer, and heart disease, drives the need for continuous and accurate drug delivery, making infusion pumps essential in inpatient and outpatient care. The U.S. is home to several key industry players, including Baxter, Becton Dickinson, and ICU Medical, all of which are actively engaged in FDA-cleared product development and smart pump innovation. Moreover, increasing investments in home healthcare and digital infusion platforms further solidify the country’s global leadership in infusion pump adoption and innovation.
Canada is a significant contributor to the North American infusion pumps market, supported by its universal healthcare system and growing focus on chronic disease management. Canadian hospitals and home care providers are increasingly integrating infusion pumps to treat conditions like cancer, infections, and pain, particularly in the elderly population.
Government-backed reimbursement programs and strict regulatory standards ensure that only safe and high-performance devices reach patients. In addition, Canada’s expanding telehealth infrastructure is facilitating the use of smart infusion pumps in remote and rural settings, enabling timely treatment and reducing hospital readmissions. With rising investments in healthcare innovation and clinical research collaborations, Canada continues to strengthen its influence in the global infusion therapy market.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 11.31 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 8.4% | 2032 Value Projection: | USD 19.89 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
BD, Fresenius Kabi, ICU Medical, Smiths Medical, Medtronic, and B. Braun Melsungen, among others |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Share
Share
About Author
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author